OALibJ  Vol.2 No.12 , December 2015
Review on Middle East Respiratory Syndrome
Abstract: Middle East respiratory syndrome (MERS) is a respiratory disease caused by a newly recognized Middle East respiratory syndrome-coronavirus (MERS-CoV). It is an RNA virus, with positive sense, single-stranded RNA genomes of 30.1 kilobase (kb). Based on its genome sequence, the virus has been classified within lineage 2C of the genus Betacoronavirus. The disease was first reported in 2012 and is now spreading to different parts of the world. Dromedary camels (Camelus dromedarius) are suggested to be the primary animal host that acts as a source of human infection by MERS-CoV. Most patients with MERS-CoV infection have been severely ill with pneumonia and acute respiratory distress syndrome, and some showed acute kidney injury. There is no specific vaccine or treatment for MERS-CoV infection other than supportive treatment. Collection of the specimens from lower respiratory tract, upper respiratory tract and serum for isolation and characterization of the virus using different techniques such as real time reverse transcription polymerase chain reaction (RT-rt PCR) and serological tests are recommended. Up to June 18, 2015, 498 of the 1327 cases have died with case fatality rate of ~38% [1]. This emerging infectious disease is a threat to human health. Proper infection-control measures including contact and airborne precautions should be implemented while managing patients with suspected MERS-CoV infection.
Cite this paper: Dires, B. and Dawo, F. (2015) Review on Middle East Respiratory Syndrome. Open Access Library Journal, 2, 1-13. doi: 10.4236/oalib.1101749.

[1]   World Health Organization (2015) MERS-CoV in the Republic of Korea at a Glance.

[2]   Bialek, S.R., Allen, D., Alvarado-Ramy, F., Arthur, R., Balajee, A., Bell, D., Best, S., Blackmore, C., Breakwell, L., Cannons, A., Brown, C., Cetron, M., Chea, N., Chommanard, C., Cohen, N., Conover, C., Crespo, A., Creviston, J., Curns, A.T., Dahl, R., Dearth, S., DeMaria, A., Echols, F., Erdman, D.D., Feikin, D., Frias, M., Gerber, S.I., Gulati, R., Hale, C., Haynes, L.M., Heberlein-Larson, L., Holton, K., Ijaz, K., Kapoor, M., Kohl, K., Kuhar, D.T., Kumar, A.M., Kundich, M., Lippold, S., Liu, L., Lovchik, J.C., Madoff, L., Martell, S., Matthews, S., Moore, J., Murray, L.R., Onofrey, S., Pallansch, M.A., Pesik, N., Pham, H., Pillai, S., Pontones, P., Pringle, K., Pritchard, S., Rasmussen, S., Richards, S., Sandoval, M., Schneider, E., Schuchat, A., Sheedy, K., Sherin, K., Swerdlow, D.L., Tappero, J.W., Vernon, M.O., Watkins, S. and Watson, J. (2014) First Confirmed Cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, Updated Information on the Epidemiology of MERS-CoV Infection, and Guidance for the Public, Clinicians, and Public Health Authorities. CDC Morbidity and Mortality Weekly Report, 63, 431.

[3]   de Groot, R.J., Baker, S.C., Baric, R.S., Brown, C.S., Drosten, C., Enjuanes, L., Fouchier, R.A., Galiano, M., Gorbalenya, A.E., Memish, Z.A., Perlman, S., Poon, L.L., Snijder, E.J., Stephens, G.M., Woo, P.C., Zaki, A.M., Zambon, M. and Ziebuhr, J. (2013) Middle East Respiratory Syndrome Coronavirus (MERSCoV): Announcement of the Coronavirus Study Group. Journal of Virology, 87, 7790-7792.

[4]   van Boheemen, S., De Graaf, M., Lauber, C., Bestebroer, T.M., Raj, V.S., Zaki, A.M., Osterhaus, A.D., Haagmans, B.L., Gorbalenya, A.E., Snijder, E.J. and Fouchier, R.A. (2012) Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans. mBio, 3, e00473-12.

[5]   Cotton, M., Lam, T.T., Watson, S.J., Palser, A.L., Petrova, V., Grant, P., Pybus, O.G., Rambaut, A., Guan, Y., Pillay, D., Kellam, P. and Nastouli, E. (2013) Full-Genome Deep Sequencing and Phylogenetic Analysis of Novel Human Betacoronavirus. Emerging Infectious Diseases, 19, 736-742.

[6]   Raj, V.S., Mou, H., Smits, S.L., Dekkers, D.H., Muller, M.A., Dijkman, R., Muth, D., Demmers, J.A., Zaki, A., Fouchier, R.A., Thiel, V., Drosten, C., Rottier, P.J., Osterhaus, A.D., Bosch, B.J. and Haagmans, B.L. (2013) Dipeptidyl Peptidase 4 Is a Functional Receptor for the Emerging Human Coronavirus-EMC. Nature, 495, 251-254.

[7]   Lu, G., Hu, Y., Wang, Q., Qi, J., Gao, F., Li, Y., Zhang, Y., Zhang, W., Yuan, Y., Bao, J., Zhang, B., Shi, Y., Yan, J. and Gao, G.F. (2013) Molecular Basis of Binding between Novel Human Coronavirus MERS-CoV and Its Receptor CD26. Nature, 500, 227-231.

[8]   CDC (2014) First Case of Middle East Respiratory Syndrome Coronavirus Infection (MERS) in the United States.

[9]   CDC (2014) Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Patients under Investigation (PUIs) for Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Version 2.1.

[10]   Corman, V.M., Eckerle, I., Bleicker, T., Zaki, A., Landt, O., Eschbach-Bludau, M., van Boheemen, S., Gopal, R., Ballhause, M., Bestebroer, T., Muth, D., Muller, M., Drexler, J., Zambon, M., Osterhaus, A., Fouchier, R. and Drosten, C. (2012) Detection of a Novel Human Coronavirus by Real-Time Reverse-Transcription Polymerase Chain Reaction. Eurosurveillance, 17, 20285.

[11]   CDC (2014) Laboratory Testing for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

[12]   Chen, Y., Chan, K., Kang, Y., Chen, H., Luk, H.K., Poon, R.S., Chan, J.F., Yuen, K., Xia, N., Lau, S.K. and Woo, P.C. (2015) A Sensitive and Specific Antigen Detection Assay for Middle East Respiratory Syndrome Coronavirus. Emerging Microbes and Infections, 4, e26.

[13]   World Health Organization (2014) WHO Risk Assessment. Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

[14]   Tina, H.S. (2013) Story One: Scientists Race to Understand Deadly New Virus: SARS-Like Infection Causes Severe Illness, but May Not Spread Quickly among People. Science News, 183, 5-6.

[15]   Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D. and Fouchier, R.A. (2012) Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. The New England Journal of Medicine, 367, 1814-1820.

[16]   Raj, S.V., Elmoubasher, A.B., Farag, A., Chantal, B.E., Reusken, C.B., Mart, M., Pas, S.D., Voermans, J., Smits, S.L., Albert, D.M., Osterhaus, A., Al-Mawlawi, N., Al Romaihi, H.E., AlHajri, M.M., El-Sayed, A.H., Khaled, A., Ghobashy, H., Alhajri, F., Al-Thani, M., Al-Marri, S.A., El-Maghraby, M.M., Marion, P.G., Koopmans, M.P. and Haagmans, B.L. (2014) Isolation of MERS Coronavirus from Dromedary Camel, Qatar, 2014. Emerging Infectious Diseases, 20, 1339-1342.

[17]   Rha, B., Rudd, J., Feikin, D., Watson, J., Curns, A.T., Swerdlow, D.L., Pallansch, M.A. and Gerber, S.I. (2015) Update on the Epidemiology of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection, and Guidance for the Public, Clinicians, and Public Health Authorities. CDC Morbidity and Mortality Weekly Report, 64, 61-62.

[18]   World Health Organization (2015) Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Summary of Current Situation, Literature Update and Risk Assessment—As of 5 February 2015.

[19]   Mackay, M.I. and Arden, E.K. (2015) Middle East Respiratory Syndrome: An Emerging Coronavirus Infection Tracked by the Crowd. Virus Research, 202, 60-88.

[20]   Azhar, E.I., Hashem, A.M., El-Kafrawy, S.A., Sohrab, S.S., Aburizaiza, A.S., Farraj, S.A., Hassan, A.M., Al-Saeed, M.S., Jamjoom, G.A. and Madani, T.A. (2014) Detection of the Middle East Respiratory Syndrome Coronavirus Genome in an Air Sample Originating from a Camel Barn Owned by an Infected Patient. mBio, 5, e01450-14.

[21]   Alagaili, A.N., Briese, T., Mishra, N., Kapoor, V., Sameroff, S.C., De Wit, E., Munster, V.J., Hensley, L.E., Zalmout, I.S., Kapoor, A., Epstein, J.H., Karesh, W.B., Daszak, P., Mohammed, O.B. and Lipkin, W.I. (2014) Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia. mBio, 5, e01002-14.

[22]   Reusken, C.B., Messadi, L., Feyisa, A., Ularamu, H., Godeke, G.J., Danmarwa, A., Dawo, F., Jemli, M., Melaku, S., Shamaki, D., Woma, Y., Wungak, Y., Gebremedhin, E.Z., Zutt, I., Bosch, B.J., Haagmans, B.L. and Koopmans, M.P. (2014) Geographic Distribution of MERS Coronavirus among Dromedary Camels, Africa. Emerging Infectious Diseases, 20, 1370-1374.

[23]   Corman, V.M., Jores, J., Meyer, B., Younan, M., Liljander, A., Said, M.Y., Gluecks, I., Lattwein, E., Bosch, B., Drexler, J., Bornstein, S., Drosten, C. and Muller, M.A. (2014) Antibodies against MERS Coronavirus in Dromedary Camels, Kenya, 1992-2013. Emerging Infectious Diseases, 20, 1319-1322.

[24]   Memish, Z.A., Mishra, N., Olival, K.J., Fagbo, S.F., Kapoor, V., Epstein, J.H., AlHakeem, R., Durosinloun, A., Al Asmari, M., Islam, A., Kapoor, A., Briese, T., Daszak, P., Al Rabeeah, A.A. and Lipkin, W.I. (2013) Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia. Emerging Infectious Diseases, 19, 1819-1823.

[25]   Reusken, C.B., Haagmans, B.L., Muller, M.A., Gutierrez, C., Godeke, G.J., Meyer, B., Muth, D., Raj, V.S., Smits-De Vries, L., Corman, V.M., Drexler, J.F., Smits, S.L., El Tahir, Y.E., De Sousa, R., Van Beek, J., Nowotny, N., Van Maanen, K., Hidalgo-Hermoso, E., Bosch, B.J., Rottier, P., Osterhaus, A., Gortázar-Schmidt, C., Drosten, C. and Koopmans, M.P. (2013) Middle East Respiratory Syndrome Coronavirus Neutralising Serum Antibodies in Dromedary Camels: A Comparative Serological Study. The Lancet Infectious Diseases, 13, 859-866.

[26]   CDC (2013) Health Alert Network. Notice to Health Care Providers: Updated Guidelines for Evaluation of Severe Respiratory Illness Associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

[27]   World Health Organization (2014) Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Summary and Literature Update—As of 9 May 2014.

[28]   Guery, B., Poissy, J., Mansouf, L., Sejourne, C., Ettahar, N., Lemaire, X., Vuotto, F., Goffard, A., Behillil, S., Enouf, V., Caro, V., Mailles, A., Che, D., Manuguerra, J.C., Mathieu, D., Fontanet, A. and Van der Werf, S. (2013) Clinical Features and Viral Diagnosis of Two Cases of Infection with Middle East Respiratory Syndrome Coronavirus: A Report of Nosocomial Transmission. Lancet, 381, 2265-2272.

[29]   Assiri, A., McGeer, A., Perl, T.M., Price, C.S., Al Rabeeah, A.A., Cummings, D.A., Alabdullatif, Z.N., Assad, M., Almulhim, A., Makhdoom, H., Madani, H., Alhakeem, R., Al-Tawfiq, J.A., Cotton, M., Watson, S.J., Kellam, P., Zumla, A.I. and Memish, Z.A. (2013) Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus. The New England Journal of Medicine, 369, 407-416.

[30]   Wikipedia (2015) Middle East Respiratory Syndrome.

[31]   Almazan, F., Marta, L., Diego, D., Sola, I., Zuñ;iga, S.A., Jose, L., Torres, N., Marquez-Jurado, S., Andrés, G. and Enjuanes, L. (2013) Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate. mBio, 4, e00650-13.

[32]   De Wilde, A.H., Raj, V.S., Oudshoorn, D., Bestebroer, T.M., Van Nieuwkoop, S., Limpens, R.W., Posthuma, C.C., Van der Meer, Y., Barcena, M., Haagmans, B.L., Snijder, E.J. and Van den Hoogen, B.G. (2013) MERS-Coronavirus Replication Induces Severe in Vitro Cytopathology and Is Strongly Inhibited by Cyclosporin A or Interferon-Alpha Treatment. Journal of General Virology, 94, 1749-1760.

[33]   Danielsson, N. and Catchpole, M. (2012) Novel Coronavirus Associated with Severe Respiratory Disease: Case Definition and Public Health Measures. Eurosurveillance, 17, pii 20282.

[34]   Kilianski, A., Mielech, A.M., Deng, X. and Baker, S.C. (2013) Assessing Activity Andinhibition of Middle East Respiratory Syndrome Coronavirus Papain-Like and 3C-Like Proteases Using Luciferase-Based Biosensors. Journal of Virology, 87, 11955-11962.

[35]   Graham, R.L., Donaldson, E.F. and Baric, R.S. (2013) A Decade after SARS: Strategies for Controlling Emerging Coronaviruses. Nature Reviews Microbiology, 11, 836-848.

[36]   Corman, V.M., Muller, M.A., Costabel, U., Timm, J., Binger, T., Meyer, B., Kreher, P., Lattwein, E., Eschbach-Bludau, M., Nitsche, A., Bleicker, T., Landt, O., Schweiger, B., Drexler, J.F., Osterhaus, A.D., Haagmans, B.L., Dittmer, U., Bonin, F., Wolff, T. and Drosten, C. (2012) Assays for Laboratory Confirmation of Novel Human Coronavirus (hCoV-EMC) Infections. Eurosurveillance, 17, pii 20334.

[37]   World Health Organization (2013) Laboratory Testing for Middle East Respiratory Syndrome Coronavirus.

[38]   Azhar, E.I., El-Kafrawy, S.A., Farraj, S.A., Hassan, A.M., Al-Saeed, M.S., Hashem, A.M. and Madani, T.A. (2014) Evidence for Camel-to-Human Transmission of MERS Coronavirus. The New England Journal of Medicine, 370, 2499-2505.

[39]   European Centre for Disease Prevention and Control (ECDC) (2013) Severe Respiratory Disease Associated with a Novel Coronavirus. Rapid Risk Assesment. ECDC, Stockholm.

[40]   Al-Tawfiq, J.A. and Memish, Z.A. (2014) What Are Our Pharmacotherapeutic Options for MERS-CoV? Expert Review of Clinical Pharmacology, 7, 235-238.

[41]   Pascal, K.E., Coleman, C.M., Mujica, A.O., Kamat, V., Badithe, A., Fairhurst, J., Hunt, C., Strein, J., Berrebi, A., Sisk, J.M., Matthews, K.L., Babb, R., Chen, G., Lai, K.V., Huang, T.T., Olson, W., Yancopoulos, G.D., Stahl, N., Frieman, M.B. and Kyratsous, C.A. (2015) Pre- and Postexposure Efficacy of Fully Human Antibodies against Spike Protein in a Novel Humanized Mouse Model of MERS-CoV Infection. Proceedings of the National Academy of Sciences of the United States of America, 112, 8738-8743.

[42]   World Health Organization (2014) Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Update on MERS-CoV Transmission from Animals to Humans, and Interim Recommendations for at Risk Groups.